Maybe hes just referring to having the financial resources to execute on the sales front while hospitals ramp up elective procedures. Take advantage of competition being out of position due to CV. Not sure you need 3 billion for that however. But this does not address innovation or really the growth he mentioned being possible.
That said, the guidance given seems overly positive considering the strong likelihood of a 2nd wave come Fall/Winter when peoples immune system weakened and Flu joins in. Given that their revenue is heavily dependent (80%) on elective surgeries they could see a worse Q4 than anticipated. Highlighting the need to diversify. That would be good use of their credit facilities imo.
To think, had they made the move 2 years ago when i thought they were, they would have been well positioned right now. However i get they needed to clear out some debt which making a move would have hurt. Then again, signing a more formal agreement would have better positioned both companies.
News 
Market Data 
Discover 
